Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Navigating India’s Growth Story: A Deep Dive into the iShares MSCI India ETF

Dieter Jaworski by Dieter Jaworski
January 28, 2026
in Analysis, Asian Markets, Emerging Markets, ETF, Value & Growth
0
iShares MSCI India ETF Stock
0
SHARES
38
VIEWS
Share on FacebookShare on Twitter

For investors seeking targeted exposure to one of the world’s fastest-growing major economies, the iShares MSCI India ETF (INDA) presents a consolidated approach. However, the fund’s concentrated nature warrants a closer examination of its holdings and recent trajectory to understand the specific opportunities and risks involved.

Recent Performance and Market Context

The ETF’s recent performance reflects a period of consolidation within the Indian equity market. Since the start of 2026, INDA has recorded a decline of nearly 6 percent, with its three-month performance also in negative territory. This movement indicates a market that has lost some momentum following an extended upward phase. Despite this short-term weakness, the fund remains a highly liquid vehicle, boasting assets under management exceeding $9 billion.

When evaluating costs, the fund’s total expense ratio (TER) of 0.61 percent is considered acceptable for a single-country ETF. Nevertheless, investors should note that a direct competitor, the Franklin FTSE India ETF (FLIN), offers a significantly lower cost structure at just 0.19 percent.

A Concentrated Portfolio with Sectoral Dependencies

Tracking the MSCI India Index via physical replication, the INDA ETF holds approximately 170 securities. A defining characteristic is its high concentration: the ten largest positions alone account for roughly 39 percent of the fund’s assets. Leading the portfolio are financial heavyweights HDFC Bank (7.7%) and ICICI Bank (5.2%), alongside the diversified conglomerate Reliance Industries (6.3%). These names, combined with IT stalwarts like Infosys and telecommunications provider Bharti Airtel, form the core of the ETF.

Should investors sell immediately? Or is it worth buying iShares MSCI India ETF?

This concentration amplifies both potential returns and risks. The fund exhibits a pronounced dependence on the Indian financial sector, which constitutes almost 30 percent of the portfolio. While strong gains from top holdings—such as Bharti Airtel’s 21 percent advance over the past year—have historically supported performance, they also increase the ETF’s vulnerability to downturns in these key industries.

Catalysts on the Horizon: Trade and Index Rebalancing

The investment case for Indian equities, and by extension the INDA ETF, may be receiving a timely boost. A significant potential catalyst is the free trade agreement between India and the European Union, finalized on January 27, 2026. This pact, which includes provisions like tariff reductions on specific goods, is viewed as a positive economic stimulus that could rejuvenate market sentiment.

Another near-term factor is the scheduled quarterly rebalancing of the underlying MSCI India Index in February 2026. This regular event may lead to adjustments in the fund’s holdings. Over the long term, the fundamental thesis continues to rest on India’s robust economic growth and corporate earnings potential.

Ad

iShares MSCI India ETF Stock: Buy or Sell?! New iShares MSCI India ETF Analysis from March 25 delivers the answer:

The latest iShares MSCI India ETF figures speak for themselves: Urgent action needed for iShares MSCI India ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

iShares MSCI India ETF: Buy or sell? Read more here...

Tags: iShares MSCI India ETF
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Ocugen Stock
Analysis

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock
Analysis

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
IBM Stock
Analysis

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Next Post
Synopsys Stock

Synopsys Sets Date for First Quarter 2026 Financial Report

Broadcom Stock

Broadcom's AI Leadership Gains Further Validation

SPDR® S&P Metals and Mining ETF Stock

US Mining ETF Approaches All-Time High on Policy and Price Surge

Recommended

Amazon Stock

Amazon Faces Regulatory Setback While Pushing AI and Retail Expansion

6 months ago
Energy Vault Holdings Stock

Energy Vault’s Strategic Pivot Gains Momentum with Major Texas Acquisition

5 months ago
COREWEAVE INC-CL A Stock

CoreWeave Shares Face Critical Earnings Test

5 months ago
Uranium Energy Stock

Uranium Energy Stock: A Market Paradox

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Ocugen Shares Slide Despite Positive Clinical Trial Results

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Trending

Energiekontor Stock
Energy & Oil

Energiekontor Stock Gains Momentum from Policy Shifts

by Rodolfo Hanigan
March 25, 2026
0

While Energiekontor's share price has faced significant headwinds this year, declining roughly 12% since January and over...

Bionxt Solutions Stock

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

March 25, 2026
Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Energiekontor Stock Gains Momentum from Policy Shifts
  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com